# A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients

> **NCT02619058** · PHASE1 · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **BIOLOGICAL:** NKT cells

## Key facts

- **NCT ID:** NCT02619058
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02619058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02619058, "A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02619058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*